Bicycle Therapeutics (BCYC) Change in Receivables (2018 - 2025)

Bicycle Therapeutics has reported Change in Receivables for 7 years, with the latest figure at $133000.0 in Q1 2025.

• For the quarter ending Q1 2025, Change in Receivables changed N/A year-over-year to $133000.0; the trailing twelve-month figure through Mar 2025 stood at $170000.0 (changed N/A YoY), and the FY2023 full-year result was -$2.5 million, down 251.25% from the prior year.
• Change in Receivables for Q1 2025 stood at $133000.0, down from $49.9 million in the prior quarter.
• The five-year high for Change in Receivables was $49.9 million in Q3 2023, with the low at -$49.8 million in Q2 2023.
• Historically, Change in Receivables has averaged -$477363.6 across 4 years, with a median of -$991000.0 in 2022.
• The largest YoY upside for Change in Receivables was 614.5% in 2023 against a maximum downside of 582.14% in 2023.
• Bicycle Therapeutics' Change in Receivables stood at $1.0 million in 2021, then surged by 98.7% to $2.0 million in 2022, then jumped by 2407.59% to $49.9 million in 2023, then slumped by 99.73% to $133000.0 in 2025.
• The last three Change in Receivables figures came in at $133000.0 (Q1 2025), $49.9 million (Q3 2023), and -$49.8 million (Q2 2023), per Business Quant data.